Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Members' Equity (Deficit) and Stock-Based Compensation Plans - Stockholder's Equity (Details)

v3.22.2.2
Stockholders' Members' Equity (Deficit) and Stock-Based Compensation Plans - Stockholder's Equity (Details) - USD ($)
 6 Months Ended
Jun. 10, 2022
Feb. 15, 2022
Jun. 30, 2022
Subsidiary, Sale of Stock [Line Items]      
Preferred stock authorized (in shares)     10,000,000
Preferred stock par value (in dollar per share)     $ 0.001
Warrants exercise price     $ 5.50
Warrants outstanding     3,220,000
Term of underwriters     45 days
Net proceeds from the offering     $ 10,167,043
Stock options      
Subsidiary, Sale of Stock [Line Items]      
Vesting Period     3 years
RSU      
Subsidiary, Sale of Stock [Line Items]      
Vesting Period     3 years
2022 Omnibus Plan      
Subsidiary, Sale of Stock [Line Items]      
Number of shares reserved for issuance 1,500,000    
Stock-based compensation recognized $ 15,407    
2022 Omnibus Plan | Stock options      
Subsidiary, Sale of Stock [Line Items]      
Unrecognized stock-based compensation related to unvested RSUs     $ 252,938
Weighted-average period over which unamortized stock-based compensation expense will recognized     2 years 11 months 12 days
2022 Omnibus Plan | RSU      
Subsidiary, Sale of Stock [Line Items]      
Unrecognized stock-based compensation related to unvested RSUs     $ 577,124
Weighted-average period over which unamortized stock-based compensation expense will recognized     2 years 11 months 12 days
Accounts Payable and Accrued Liabilities      
Subsidiary, Sale of Stock [Line Items]      
Offering expenses     $ 1,045,000
Initial public offering      
Subsidiary, Sale of Stock [Line Items]      
Units issued in IPO   2,800,000  
Number of shares of common stock   1  
Number of warrants to purchase each share   1  
Warrants exercise price   $ 5.50  
Warrants exercisable term   5 years  
Over-Allotment Option      
Subsidiary, Sale of Stock [Line Items]      
Warrants exercise price     $ 0.012
Warrants outstanding     420,000
Warrants issued     21,000
Additional units issued     140,000
Exercise price of additional units     $ 6.60
Public offering price per unit sold     120.00%
Public offering price per warrant sold     120.00%
Over-Allotment Option | Maximum      
Subsidiary, Sale of Stock [Line Items]      
Warrants issued     420,000
Common Class A      
Subsidiary, Sale of Stock [Line Items]      
Common stock , Authorized     160,000,000
Common stock , par value     $ 0.001
Common Class A | Over-Allotment Option      
Subsidiary, Sale of Stock [Line Items]      
Warrants outstanding     2,800,000
Intrinsic value     $ 0
Warrants issued     420,000
Common Class B      
Subsidiary, Sale of Stock [Line Items]      
Common stock , Authorized     20,000,000
Common stock , par value     $ 0.001
DDH LLC      
Subsidiary, Sale of Stock [Line Items]      
Noneconomic voting rights (as a percent)     100.00%
DDH LLC | Woolford      
Subsidiary, Sale of Stock [Line Items]      
Aggregate purchase price of units issued     $ 14,246,251
DDH LLC | Accrued liabilities | Woolford      
Subsidiary, Sale of Stock [Line Items]      
Remaining amount payable     $ 3,962,162
DDH LLC | Common Units | Woolford      
Subsidiary, Sale of Stock [Line Items]      
Remaining number of units issuable     5,637
DDH LLC | Class B Preferred Units. | Woolford      
Subsidiary, Sale of Stock [Line Items]      
Remaining number of units issuable     7,046
DDH LLC | Initial public offering      
Subsidiary, Sale of Stock [Line Items]      
Number of shares of common stock     11,378,000
DDH LLC | Initial public offering | Woolford      
Subsidiary, Sale of Stock [Line Items]      
Purchase price paid     $ 10,284,089